证券记录 · 已归档季度
ABBV
AbbVie Inc. · Healthcare · Drug Manufacturers - General
27被追踪持有人
0Δ持有人
673.15M持有股份
$155.83B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +1.3% · 净新建仓位 -3.7% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | +1 | 2.86M | $728.95M | +1 | n/a |
| Q2 2026 | 181 | +6 | 1.06B | $267.14B | +9 | −4 |
| Q1 2026 | 179 | -3 | 1.05B | $227.15B | +2 | −6 |
| Q4 2025 | 181 | -3 | 1.14B | $259.75B | +1 | −3 |
| Q3 2025 | 27 | 0 | 673.15M | $155.83B | n/a | −1 |
| Q2 2025 | 25 | +2 | 519.81M | $96.45B | +2 | n/a |
| Q1 2025 | 20 | 0 | 175.76M | $36.80B | n/a | n/a |
| Q4 2024 | 20 | 0 | 178.61M | $31.72B | n/a | n/a |
| Q3 2024 | 19 | 0 | 95.00M | $18.73B | +1 | −1 |
| Q2 2024 | 19 | n/a | 90.79M | $15.55B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 177.75M | +0.2% | $41.16B | 0.6% | ▲ Add | 2 | SEC ↗ ×7 |
| 2 | BlackRock ✦ (被动) | 145.98M | -1.0% | $33.80B | 0.6% | ▼ Trim | 2 | SEC ↗ ×23 |
| 3 | JPMorgan Chase ✦ | 113.07M | n/a | $26.18B | 0.8% | n/c | 1 | SEC ↗ ×46 |
| 4 | State Street Global Advisors ✦ (被动) | 79.82M | -0.2% | $18.48B | 0.6% | ▼ Trim | 4 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 41.65M | n/a | $9.64B | 0.6% | n/c | 1 | SEC ↗ ×23 |
| 6 | Geode Capital Management ✦ (被动) | 40.44M | +3.2% | $9.33B | 0.6% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Fidelity (FMR) ✦ | 21.04M | +0.2% | $4.87B | 0.3% | ▲ Add | 2 | SEC ↗ ×6 |
| 8 | Goldman Sachs Group ✦ | 13.40M | n/a | $3.10B | 0.4% | n/c | 1 | SEC ↗ ×6 |
| 9 | T. Rowe Price ✦ | 10.60M | +17.0% | $2.45B | 0.3% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Wellington Management ✦ | 10.54M | +457.4% | $2.44B | 0.4% | ▲ Add | 6 | SEC ↗ ×9 |
| 11 | Capital World Investors ✦ | 6.34M | -2.1% | $1.47B | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 3.11M | -4.5% | $719.03M | 0.6% | ▼ Trim | 5 | SEC ↗ ×2 |
| 13 | Millennium Management ✦ | 2.02M | -17.6% | $466.72M | 0.4% | ▼ Trim | 6 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 1.84M | +14.0% | $427.14M | 0.7% | ▲ Add | 6 | SEC ↗ |
| 15 | Marshall Wace ✦ | 1.28M | -7.4% | $295.72M | 0.3% | ▼ Trim | 6 | SEC ↗ ×3 |
| 16 | D. E. Shaw & Co. ✦ | 1.12M | -27.4% | $259.13M | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | Renaissance Technologies ✦ | 928.07K | -52.7% | $214.89M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 926.84K | +55.0% | $209.65M | 0.1% | ▲ Add | 6 | SEC ↗ ×7 |
| 19 | Point72 Asset Management ✦ | 359.44K | +6799.1% | $83.23M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 275.85K | -2.7% | $63.87M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 260.69K | -56.4% | $60.36M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 22 | Arrowstreet Capital ✦ | 184.69K | -41.7% | $42.76M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 163.18K | -36.2% | $37.78M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 48.47K | +31.8% | $11.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | GAMCO Investors ✦ | 15.27K | -3.1% | $3.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 26 | Dodge & Cox ✦ | 10.47K | 0.0% | $2.42M | 0.0% | Held | 6 | SEC ↗ |
| 27 | Harris Associates (Oakmark) ✦ | 3.16K | 0.0% | $732,361 | 0.0% | Held | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $4.29B | 曾为 0.5% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 4,042 持有人, 1.24B 股份, $260.03B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 14
Donoghoe Nicholas
Officer · 32.71K 股 · $8.18M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据